Peter A. Andreasen
Aarhus C, 8000, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Embelin ameliorated sepsis-induced disseminated intravascular coagulation intensities by simultaneously suppressing inflammation and thrombosis.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 04, 2020
Suppression of Tumor Growth and Metastases by Targeted Intervention in Urokinase Activity with Cyclic Peptides.
Journal: Journal of medicinal chemistry
Published: February 02, 2019
Origin and diversification of the plasminogen activation system among chordates.
Journal: BMC evolutionary biology
Published: April 26, 2018
Cleavage of peptidic inhibitors by target protease is caused by peptide conformational transition.
Journal: Biochimica et biophysica acta. General subjects
Published: April 22, 2018
Ligand binding modulates the structural dynamics and activity of urokinase-type plasminogen activator: A possible mechanism of plasminogen activation.
Journal: PloS one
Published: January 05, 2018
PAI1 mediates fibroblast-mast cell interactions in skin fibrosis.
Journal: The Journal of clinical investigation
Published: December 07, 2017
Structural Principles in the Development of Cyclic Peptidic Enzyme Inhibitors.
Journal: International journal of biological sciences
Published: June 23, 2017
Discovery of a novel conformational equilibrium in urokinase-type plasminogen activator.
Journal: Scientific reports
Published: February 16, 2017
Latency transition of plasminogen activator inhibitor type 1 is evolutionarily conserved.
Journal: Thrombosis and haemostasis
Published: February 13, 2017
A Conjugate of Two tPA-Binding RNA Aptamers Efficiently Inhibits Fibrinolysis.
Journal: Nucleic acid therapeutics
Published: January 05, 2017
Last Updated: 09/26/2026